{"id":"W4415942647","doi":"10.1016/j.annonc.2025.08.2475","title":"1851MO Pembrolizumab plus chemotherapy (PEM + CT) versus pembrolizumab (PEM) as first-line therapy for advanced NSCLC with PD-L1 tumor proportion score (TPS) ≥50%: Open-label, phase III, randomized trial (PAULIEN)","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Pembrolizumab; Chemotherapy; Randomized controlled trial; Phases of clinical research; Chemotherapy regimen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008042449,0.001126792,0.00167967,0.0002896014,0.000359061,0.0009971372,0.0006089217,0.0009946754,0.006069566],"category_scores_gemma":[0.0006342841,0.0005015573,0.001179726,0.0002557244,0.0006465433,0.0009549714,0.0003619731,0.002531127,0.00108427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008309808,"about_ca_system_score_gemma":0.00103981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001639465,"about_ca_topic_score_gemma":0.004401463,"domain_scores_codex":[0.9997886,0.00008144951,0.00001099411,0.0000565661,0.00001752826,0.00004494091],"domain_scores_gemma":[0.9997599,0.00005196622,0.00004786937,0.00001547588,0.00001304295,0.0001117937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9318208,0.008369199,0.0009377834,0.0009874341,0.001382729,0.00003829585,0.00006970678,0.00080883,0.005929647,0.0002937854,0.002194947,0.04716689],"study_design_scores_gemma":[0.9153423,0.07790486,0.003079908,0.00005509635,0.0006768112,0.00003915174,0.00003087847,0.0007539488,0.0005868868,0.0002063334,0.001308554,0.00001528855],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839198,0.0056087,0.0007375662,0.0009752088,0.0005874975,0.002619222,0.001390117,0.0001723626,0.003989474],"genre_scores_gemma":[0.984335,0.003351333,0.001678709,0.001211078,0.0003016028,0.00206411,0.00134513,0.00002682612,0.005686276],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006069566,"threshold_uncertainty_score":0.02030474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08929967220707699,"score_gpt":0.4317234721105517,"score_spread":0.3424237999034747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}